The Bio Report
By Levine Media Group
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Levine Media Group
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 71
Reviews: 0
Episodes: 565
Description
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
| Episode | Date |
|---|---|
|
Making Medicines for a World of People with Cancer
|
May 28, 2025 |
|
Harnessing Myeloid Cells to Attack Cancer
|
May 21, 2025 |
|
Drawing Lessons from the COVID Pandemic
|
May 14, 2025 |
|
A Bet that Myostatins Can Muscle Out Obesity
|
May 07, 2025 |
|
Making Whole-Eye Transplantation a Reality
|
Apr 30, 2025 |
|
Synbio Companies Come to Grips with the One “Omic” that Matters
|
Apr 23, 2025 |
|
Searching for Safer Pain Medications
|
Apr 16, 2025 |
|
Bridging the Translational Divide in Healthcare AI
|
Apr 09, 2025 |
|
Seeking Long-Term Pain Relief from a Drug-Free Injection
|
Apr 02, 2025 |
|
Engaging Hard-to-Target Receptors with Antibodies that Activate
|
Mar 26, 2025 |
|
An Insider’s View of the Patent Fights that Shaped the Biotech Industry
|
Mar 19, 2025 |
|
Restoring Balance to the Immune System in Allergic Diseases
|
Mar 12, 2025 |
|
Turning Natural Killers into Off-the-Shelf Therapies for Autoimmune Disease
|
Mar 05, 2025 |
|
Combining an Antibody and siRNA to Treat Hepatitis B
|
Feb 26, 2025 |
|
Looking at the Promise of GLP-1 Agonists Beyond Obesity
|
Feb 19, 2025 |
|
An Off-the-Shelf Cancer Vaccine Faces a Final Clinical Hurdle in NSCLC
|
Feb 12, 2025 |
|
A Nose for Attacking Brain Cancer
|
Feb 05, 2025 |
|
An Unnatural Approach to Undruggable Targets
|
Jan 29, 2025 |
|
Expanding the Drug Developer’s Chemical Universe
|
Jan 22, 2025 |
|
Take 100 Megabytes a Day and Call Me in the Morning
|
Jan 15, 2025 |
|
Extracting the Benefits of Psychedelics
|
Jan 08, 2025 |
|
A Magellan that Circumnavigates Active Binding Sites
|
Jan 01, 2025 |
|
A Very Meh-Ry Biotech Year and What’s Ahead in 2025
|
Dec 25, 2024 |
|
Using Light to Biomanufacture a Steak
|
Dec 18, 2024 |
|
Sit, Stay, and Heal: Bringing Precision Medicine to Dogs, then Humans
|
Dec 11, 2024 |
|
Targeting the Undruggable Proteome
|
Dec 04, 2024 |
|
Preventing a Deadly Disease by Detecting It Before It Becomes Cancer
|
Nov 26, 2024 |
|
Getting Tumors to Say “Eat Me”
|
Nov 20, 2024 |
|
Targeting the Dark Matter of the Genome to Treat Diseases
|
Nov 13, 2024 |
|
Using AI to Discover Small Molecule Alternatives to Biologics
|
Nov 06, 2024 |
|
A BET on a Novel Approach to Treat Autoimmune Conditions
|
Oct 30, 2024 |
|
Cell Therapies that Can Do a Solid for People with Cancer
|
Oct 23, 2024 |
|
Going to Extremes to Discover New Drugs
|
Oct 16, 2024 |
|
Targeting Senescent Cells to Treat Aging-Related Diseases
|
Oct 09, 2024 |
|
Bringing Cellular Diversity into Sharper Focus
|
Oct 02, 2024 |
|
Developing Cancer Therapies for When Damage Control Goes Awry
|
Sep 25, 2024 |
|
Delivering the Goods
|
Sep 25, 2024 |
|
Swimming in the New Oil
|
Sep 11, 2024 |
|
Does This Drug Represent “A Paradigm Shift for Small Molecule Drug Development?”
|
Sep 04, 2024 |
|
Exploring the Promise and Peril of CRISPR
|
Aug 28, 2024 |
|
Transforming Protein Engineering with Generative AI
|
Aug 21, 2024 |
|
Delivering Peptide Therapies Orally
|
Aug 14, 2024 |
|
Creating A Drug Delivery ARMMs Race
|
Aug 07, 2024 |
|
A Seek and Destroy Approach to Disease-Causing Proteins
|
Jul 31, 2024 |
|
Teaching Tolerance to Address Autoimmune Diseases
|
Jul 24, 2024 |
|
A Bet That the Next Blockbuster May Already Be Inside You
|
Jul 17, 2024 |
|
A Big Mac Attack to Fight Cancer
|
Jul 10, 2024 |
|
Getting Animated about Bioliteracy
|
Jul 03, 2024 |
|
Reshaping Clinical Trial Designs with Real-World Data
|
Jun 26, 2024 |
|
Using Generative AI to Produce Precise Gene Editors
|
Jun 19, 2024 |
|
Enabling the Nervous System to Repair Itself
|
Jun 12, 2024 |
|
Overcoming Barriers to Delivering Large Molecules to the Brain
|
Jun 05, 2024 |
|
Developing Complex Therapies to Tackle Complex Diseases
|
May 29, 2024 |
|
How Solving a Problem with Genetic Medicines May Solve Another with Infectious Diseases
|
May 22, 2024 |
|
Boosting the Power of Dendritic Cancer Vaccines
|
May 15, 2024 |
|
Overcoming Resistance in Cancer with Chemistry
|
May 08, 2024 |
|
Teaching an Old Drug a New Trick to Prevent Lyme Disease
|
May 01, 2024 |
|
A New Class of Cell Therapies to Target Solid Tumors
|
Apr 24, 2024 |
|
Targeting the Tumor Microenvironment with Lipid-Based Immunotherapies
|
Apr 17, 2024 |
|
A Company Born from a Father Who Wore His Heart on His Sleeve
|
Apr 10, 2024 |
|
Using AI to Improve Burn Care
|
Apr 03, 2024 |
|
A Home for Biotech in the City that Never Sleeps
|
Mar 27, 2024 |
|
Biopharma R&D Growing Stronger
|
Mar 20, 2024 |
|
The Benefits of Having a Multitude of Cins
|
Mar 13, 2024 |
|
Making ADCs Smarter and Safer with a Simple Twist of Fate
|
Mar 06, 2024 |
|
Targeting a Natural Repair System to Restore Brain Health
|
Feb 28, 2024 |
|
Programing Cells in a Predictable and Scalable Way
|
Feb 21, 2024 |
|
Why DNA May Be the Data Storage Medium of the Future
|
Feb 14, 2024 |
|
Scouring Genetic Variation within Our Cells for Drug Targets
|
Feb 07, 2024 |
|
Correcting Gene Dysregulation to Treat Diseases
|
Jan 31, 2024 |
|
Using Technology to Regain Abilities after Spinal Cord Injury
|
Jan 24, 2024 |
|
Why Drug Developers Have a Growing Interest in Targeting Mitochondria
|
Jan 17, 2024 |
|
Beefing Up Computational Muscle to Understand Molecular Activity of Drug Candidates
|
Jan 10, 2024 |
|
Targeting a Multitude of CIN in Cancer Cells
|
Jan 03, 2024 |
|
The Year in Biotech and What’s Ahead in 2024
|
Dec 27, 2023 |
|
Transforming Healthcare with Data
|
Dec 20, 2023 |
|
Realizing the Promise of IL-2 Therapies with AI
|
Dec 13, 2023 |
|
Unlocking Real-World Data to Improve Outcomes
|
Dec 06, 2023 |
|
A Silicon Valley Entrepreneur Investing at the Intersection of Tech and Biotech
|
Nov 29, 2023 |
|
A Company Betting Its Physics-Based AI Will Fuel a Quantum Leap in Drug Discovery
|
Nov 22, 2023 |
|
Detecting Alzheimer’s Disease Early through a Blood Test
|
Nov 15, 2023 |
|
Addressing Supply-Chain Challenges Underlying Drug Shortages with Synthetic Biology
|
Nov 08, 2023 |
|
Building Better and More Affordable Vaccines
|
Nov 01, 2023 |
|
Overcoming Resistance to Targeted Therapies
|
Oct 25, 2023 |
|
Using Tumor Gene Therapy to Overcome Barriers to Immunotherapies
|
Oct 18, 2023 |
|
Using AI to Generate Mini-Protein Therapeutics
|
Oct 11, 2023 |
|
Inhibiting Cell Death to Preserve Vision in Retinal Diseases
|
Oct 04, 2023 |
|
Leveraging Generative AI to Design Therapeutic Antibodies
|
Sep 27, 2023 |
|
Managing Pain without Addiction
|
Sep 20, 2023 |
|
Using AI to Match Cancer Patients to their Best Treatment Options
|
Sep 13, 2023 |
|
A Venture Capitalist’s View of the Current Biotech Landscape
|
Sep 06, 2023 |
|
Realizing the Therapeutic Potential of Cytokines by Making them Context Dependent
|
Aug 30, 2023 |
|
Targeting Cancer and Autoimmune Conditions with Donor-Derived EBV T Cells
|
Aug 23, 2023 |
|
Reprogramming the Tumor Microenviroment to Activate an Immune Response
|
Aug 16, 2023 |
|
Making Safer and More Effective Vaccines with Targeted mRNA
|
Aug 09, 2023 |
|
Addressing a Global Need with RNA Vaccines and Immunotherapies
|
Aug 02, 2023 |
|
Targeting Bacteria in Chronic Diseases
|
Jul 26, 2023 |
|
Targeting Solid Tumors with Off-The-Shelf CAR T Therapies
|
Jul 19, 2023 |
|
Reimagining the Development of Immunotherapies with a Venture Studio
|
Jul 12, 2023 |
|
Repairing the Body with Advanced Cell Therapies
|
Jul 05, 2023 |
|
Achieving Precision with AI Pathology
|
Jun 28, 2023 |
|
Inducing Potent and Durable T Cell Responses to Fight Disease
|
Jun 21, 2023 |
|
Developing Immunotherapies that Target the Drivers of Cancer
|
Jun 14, 2023 |
|
Using Phase 0 Trials to Bring Precision Medicine to Treating Brain Tumors
|
Jun 07, 2023 |
|
Restoring Feeling and Function to Damaged Nerves
|
May 31, 2023 |
|
Enlisting Vaccines in the Fight Against Chronic Diseases
|
May 24, 2023 |
|
Extending the Reach of Protein Degradation Therapies
|
May 17, 2023 |
|
Growing the Bioeconomy
|
May 10, 2023 |
|
Developing Targeted Therapies to Address Resistance in Cancer
|
May 03, 2023 |
|
It Takes a Village
|
Apr 26, 2023 |
|
Bringing Stick-to-itiveness to Regenerative Medicine
|
Apr 19, 2023 |
|
A Biopharma Downturn or Return to Trend
|
Apr 12, 2023 |
|
Treating Aging-Related Disease by Targeting Molecular Drivers of Aging
|
Apr 05, 2023 |
|
Engineering Better Cell Therapies for Cancers
|
Mar 29, 2023 |
|
Targeting a Regulator of Inflammation to Treat Alzheimer’s Disease
|
Mar 22, 2023 |
|
Enabling Regenerative Therapies without Immunosuppression
|
Mar 15, 2023 |
|
Making Vaccine and Biotherapeutic Production Fast and Affordable
|
Mar 08, 2023 |
|
Forcing Cancers to Reveal Themselves
|
Mar 01, 2023 |
|
Making Clinical Trials Diverse and Accessible
|
Feb 23, 2023 |
|
Mining Bugs for Drugs
|
Feb 16, 2023 |
|
A Company That Bets Its Therapies Will Click with Patients
|
Feb 09, 2023 |
|
A Company Where It takes Guts and Brains to Develop Drugs
|
Feb 02, 2023 |
|
Changing Outcomes with Data
|
Jan 25, 2023 |
|
Treating Psychiatric Conditions with Tripless Psychedelics
|
Jan 19, 2023 |
|
How AI Is Finding Its Way into Unexpected Places in Biopharma Companies
|
Jan 12, 2023 |
|
Searching the Dark Matter of the Proteome to Develop New Therapies
|
Jan 05, 2023 |
|
The Year in Biotech and What’s Ahead in 2023
|
Dec 29, 2022 |
|
Targeting a Novel Checkpoint to Treat Cancer and Autoimmune Conditions
|
Dec 22, 2022 |
|
The Growing Need for Biosecurity Vigilance
|
Dec 15, 2022 |
|
Enlisting Next-Generation Cytokine Immunotherapies in the Fight Against Cancer
|
Dec 08, 2022 |
|
Engineering Safer and More Effective Cell Therapies
|
Dec 01, 2022 |
|
Changing Drug Discovery for Neuropsychiatric Disorders with Phenotypic Screens
|
Nov 23, 2022 |
|
Using Virtual Reality-Guided Mindfulness to Treat Chronic Pain in Cancer Patients
|
Nov 17, 2022 |
|
Activating the Adaptive and Innate Immune Systems to Fight Cancer
|
Nov 10, 2022 |
|
A Longevity Fund Focused on Young Companies
|
Nov 03, 2022 |
|
Learning from “Elite” Responders to Develop Better Immunotherapies
|
Oct 27, 2022 |
|
Bringing Precision Medicine to the Treatment of Obesity
|
Oct 20, 2022 |
|
Expanding the Promise of RNA Therapies
|
Oct 13, 2022 |
|
Triggering a Systemic Immune Response Against Cancer
|
Oct 06, 2022 |
|
Targeting RNA Dysregulation in Cancer
|
Sep 29, 2022 |
|
Building a Pipeline of Next-Generation Kinase Inhibitors
|
Sep 22, 2022 |
|
Rethinking How Cell and Gene Therapies Are Made to Improve Accessibility
|
Sep 15, 2022 |
|
Developing Next-Generation Radiopharmaceuticals
|
Sep 08, 2022 |
|
Why Great Science and Data Aren’t Enough
|
Sep 01, 2022 |
|
Targeting Sugars that Let Cancers Evade the Immune System
|
Aug 25, 2022 |
|
Engineering Stem Cells to Withstand Targeted Therapies
|
Aug 18, 2022 |
|
Targeting a Convergence of Signaling Pathways that Drive the Growth and Spread of Cancer
|
Aug 11, 2022 |
|
Moving from Preservation to Restoration with Off-the-Shelf Cell Therapies
|
Aug 04, 2022 |
|
Using Gene Therapies to Treat Chronic, Inflammatory Conditions
|
Jul 28, 2022 |
|
Unlocking the Full Potential of Antibody Therapies
|
Jul 21, 2022 |
|
Combatting Superbugs and Emerging Viruses
|
Jul 14, 2022 |
|
How a Plant-Derived Gel Halts Bleeding in Seconds
|
Jul 07, 2022 |
|
Exploiting a Vulnerability in Cancers
|
Jun 30, 2022 |
|
Democratizing AI
|
Jun 23, 2022 |
|
A Rapid Onset Nasal Spray to Treat Mental Health Conditions
|
Jun 16, 2022 |
|
A Regenerative Medicine Company Puts Its Off-the-Shelf Vessel Replacements to the Test in Ukraine
|
Jun 09, 2022 |
|
Battling Resistance in Tumors with “Pan-Variant” Kinase Inhibitors
|
Jun 02, 2022 |
|
Treating Disease by Editing Genes in the Microbiome
|
May 26, 2022 |
|
Embracing the Promise of Natural Killer Cells in the Fight Against Cancer
|
May 19, 2022 |
|
Addressing Neurodegenerative Disease by Suppressing a Hyper Immune Response
|
May 12, 2022 |
|
Bringing Precision Medicine to Psychiatry
|
May 05, 2022 |
|
Attacking Neurodegenerative Diseases with Protein Degraders
|
Apr 28, 2022 |
|
Restoring Immune Activity While Suppressing Cancer Proliferation
|
Apr 21, 2022 |
|
A New Model for Preventing Life-Threatening Blood Clots
|
Apr 14, 2022 |
|
The Race to Live Forever
|
Apr 07, 2022 |
|
A Model for Moving from Breakthrough to Blockbuster
|
Mar 31, 2022 |
|
Building the Next-Generation of Cell and Gene Therapies
|
Mar 24, 2022 |
|
Building Small Molecule Drugs that Are Superior to Biologics
|
Mar 17, 2022 |
|
A New Class of Cancer Therapies Targets Solid Tumors with a Dual Action
|
Mar 10, 2022 |
|
A Pursuit of Off-The-Shelf CAR-T Therapies
|
Mar 03, 2022 |
|
Mapping the Human Proteome
|
Feb 24, 2022 |
|
Gene Therapy Provides Hope to Hemophilia B Patients
|
Feb 17, 2022 |
|
Making Data-Driven Medicine a Reality
|
Feb 10, 2022 |
|
A Neuroscientist Turned Venture Investor Discusses TechBio Investing
|
Feb 03, 2022 |
|
A Nonprofit Seeks to Make Cell and Gene Therapies Affordable Worldwide
|
Jan 27, 2022 |
|
Disposing Toxic Proteins to Treat Neurodegenerative Diseases
|
Jan 20, 2022 |
|
Repurposing a Drug for Parasitic Infections as a Targeted GI Therapy
|
Jan 13, 2022 |
|
Targeting Chronic, Low-Grade Inflammation to Address Diseases of Aging
|
Jan 06, 2022 |
|
The Year in Biotech and What’s Ahead in 2022
|
Dec 30, 2021 |
|
Restoring the Guardian of the Genome to Fight Tumors
|
Dec 23, 2021 |
|
Advancing a Cell Therapy with the Potential to Cure HIV
|
Dec 16, 2021 |
|
Harnessing More Efficient Organisms to Reshore BioManufacutring
|
Dec 09, 2021 |
|
Using Digital Health Technology to Bring the Trial to the Patient
|
Dec 02, 2021 |
|
Using the Body’s Housecleaning Mechanism to Target Undruggable Proteins
|
Nov 24, 2021 |
|
Advocating for the Extension of Healthy Life
|
Nov 18, 2021 |
|
Using Donated Living Skin as an Alternative to Animal Testing
|
Nov 11, 2021 |
|
A Platform to Scale the Production of Personalized Cell Therapies
|
Nov 04, 2021 |
|
Developing Small Molecule Therapies to Target Proteins Only Biologics Have Been Able to Hit
|
Oct 28, 2021 |
|
Targeting Solid Tumors with Oncolytic Viruses
|
Oct 20, 2021 |
|
Reinventing the Discovery and Cell Line Development of Biotherapeutics
|
Oct 14, 2021 |
|
Engineering Off-the-Shelf Cell Therapies to Target Solid Tumors
|
Oct 07, 2021 |
|
Democratizing Drug Discovery
|
Sep 30, 2021 |
|
Scaling Genetic Counseling Services with AI
|
Sep 23, 2021 |
|
Programming Cell Therapies to Overcome Solid Tumor Defense Systems
|
Sep 16, 2021 |
|
Using Liquid Biopsies to Diagnose Infectious Diseases
|
Sep 09, 2021 |
|
Striking Hepatitis B at Its Core
|
Sep 02, 2021 |
|
Modulating Serotonin with Psychedelics to Treat Neuropsychiatric Conditions
|
Aug 26, 2021 |
|
A Procedural Therapy Seeks to Address Type 2 Diabetes at Its Root Cause
|
Aug 19, 2021 |
|
Building a Better Path to Neurotherapeutics
|
Aug 12, 2021 |
|
Taking a Portfolio Approach to Immuno-Oncology
|
Aug 05, 2021 |
|
Engineering Life to Reach New Worlds
|
Jul 29, 2021 |
|
Targeting Cancer Drug Side Effects at Their Source
|
Jul 22, 2021 |
|
Mapping the Universe of Human Proteins
|
Jul 15, 2021 |
|
Fighting Disease by Modulating the Translation of Proteins
|
Jul 08, 2021 |
|
Fixing Biopharma’s R&D Productivity by Taking a Cue from the Tech Industry
|
Jul 01, 2021 |
|
An Affordable and Widely Available Drug Offers Global Hope against COVID
|
Jun 24, 2021 |
|
A Gene Therapy to Program the Body to Produce a Treatment for Osteoarthritis
|
Jun 17, 2021 |
|
A Test for Data-Driven Drug Development
|
Jun 10, 2021 |
|
Bridging the Gulf Between the Promise and Reality of Precision Health
|
Jun 03, 2021 |
|
Using Synthetic Biology to Craft One-Time, Programmable mRNA Therapeutics
|
May 27, 2021 |
|
Using a Digital Cognitive Behavior Therapy to Treat Diabetes and Heart Disease
|
May 20, 2021 |
|
Disrupting Pain Signals with Precision
|
May 12, 2021 |
|
A Diagnostics Company Moves to Developing Precision Cancer Therapies
|
May 06, 2021 |
|
Characterizing the Immunome at Scale
|
Apr 29, 2021 |
|
Delivering Oxygen to Tissue in Need
|
Apr 22, 2021 |
|
Using Gene Therapy to Create a Drug Biofactory within a Patient
|
Apr 15, 2021 |
|
Finding New Uses for TNF Inhibitors
|
Apr 08, 2021 |
|
Using AI to Map the Undiscovered World of Bioactive Compounds in Plants
|
Apr 01, 2021 |
|
Improving the Delivery of Drugs through Thin Film Freezing
|
Mar 25, 2021 |
|
Using CRISPR to Target RNA Instead of DNA
|
Mar 18, 2021 |
|
An Antisense Pioneer Brings Custom Treatments to Patients with Ultra-Rare Conditions
|
Mar 11, 2021 |
|
Managing Neurodegenerative Diseases with Better Data to Improve Outcomes
|
Mar 04, 2021 |
|
A Small Molecule Cancer Drug That Promotes an Adaptive Immune Response
|
Feb 25, 2021 |
|
Sloan-Kettering Spin-Out Harnesses AI to Diagnose Cancer
|
Feb 18, 2021 |
|
Bringing Innovation to Cell and Gene Therapy Manufacturing
|
Feb 11, 2021 |
|
Tapping Psychedelics for their Anti-Inflammatory Powers
|
Feb 04, 2021 |
|
Advancing Cell Therapies Beyond Cancer
|
Jan 28, 2021 |
|
How the Pandemic Transformed a Small Diagnostics Company
|
Jan 21, 2021 |
|
Eliminating Security, Privacy, and Regulatory Burdens with Synthetic Data
|
Jan 14, 2021 |
|
Using Computational Discovery to Build Better Immunotherapies
|
Jan 07, 2021 |
|
The Year in Biotech and What’s Ahead in 2021
|
Dec 31, 2020 |
|
Bringing Precision Cancer Care to Dogs
|
Dec 24, 2020 |
|
As COVID-19 Vaccines Ship, One Company Brings Innovation to the Vials
|
Dec 17, 2020 |
|
Advancing an Antibody to Prevent and Treat Cytokine Storms in COVID-19
|
Dec 10, 2020 |
|
Using AI Created Digital Twins to Accelerate Clinical Trials
|
Dec 03, 2020 |
|
Modulating RNA to Quell Disease
|
Nov 26, 2020 |
|
A Quest to Extend Life through Early Disease Detection
|
Nov 19, 2020 |
|
Modulating a Gatekeeper of Cellular Metabolism to Treat a Range of Diseases
|
Nov 12, 2020 |
|
Finding the Best Cell for the Job
|
Nov 05, 2020 |
|
Transforming Clinical Trials with Digital Technology
|
Oct 29, 2020 |
|
Designing Immunotherapies that Can Overcome Recurrence and Resistance
|
Oct 22, 2020 |
|
Extending Precision Medicine Beyond Cancer
|
Oct 15, 2020 |
|
Growing Biologics
|
Oct 08, 2020 |
|
An Experimental COVID-19 Vaccine Begins Human Clinical Trials
|
Oct 01, 2020 |
|
Speeding the Delivery of CAR-T Therapies While Cutting the Cost
|
Sep 24, 2020 |
|
Transforming Infused Biologics into Injectables
|
Sep 17, 2020 |
|
A Novel Approach to NASH That May Have Benefits for COVID 19 As Well
|
Sep 10, 2020 |
|
Will a Focus on Protein Dysregulation Help Prothena Break from the Fold
|
Sep 03, 2020 |
|
After FDA Set Back, AI Driven Drug Company Advances with New CEO
|
Aug 27, 2020 |
|
A Gamified Therapy System Helps People with Brain Injury Recover
|
Aug 20, 2020 |
|
Genentech Drug Offers Oral, at-Home Option for SMA Patients
|
Aug 13, 2020 |
|
Enabling Precision Medicine through Proteomics
|
Aug 06, 2020 |
|
Battling Drug-Resistant Fungal Infections
|
Jul 30, 2020 |
|
Making Colorectal Cancer Screening Less of a Pain in the Ass
|
Jul 23, 2020 |
|
Targeting Diseases of Aging at a Cellular Level
|
Jul 16, 2020 |
|
Cracking the Immune System with AI
|
Jul 09, 2020 |
|
Using AI to Improve Drug Companies’ Regulatory Performance
|
Jul 02, 2020 |
|
Delivering Biologics Orally
|
Jun 25, 2020 |
|
Turning Proteins into Device Coatings that Provide Therapeutic Benefits
|
Jun 18, 2020 |
|
Testing if an Approved Antiviral May Prevent COVID-19 Outbreaks
|
Jun 11, 2020 |
|
Using AI to Crack COVID-19
|
Jun 04, 2020 |
|
Why An Experimental Therapy for Inflammatory Disorders Could Help the Fight Against COVID-19
|
May 28, 2020 |
|
Modernizing Phage Therapy to Kill Multidrug-Resistant Bacteria
|
May 21, 2020 |
|
A Rare Disease Drug Hunter Turns His Attention to COVID-19
|
May 14, 2020 |
|
What It Will Take to Move Beyond the Pandemic
|
May 06, 2020 |
|
Reading, Writing, and Erasing the Way to Epigenetic Cancer Therapies
|
Apr 30, 2020 |
|
Better Immunotherapies Through Chemistry
|
Apr 23, 2020 |
|
Bringing the Trial to the Patient
|
Apr 16, 2020 |
|
Controlling the Activity of Cell and Gene Therapies with Precision
|
Apr 09, 2020 |
|
Why Soon-Shiong Thinks His Triangle Offense for Cancer Can Be Applied to COVID-19
|
Apr 02, 2020 |
|
COVID-19, Vaccine Development, and Global Health Lessons from Ebola
|
Mar 25, 2020 |
|
Improving Cancer Outcomes with Early Diagnosis
|
Mar 19, 2020 |
|
Making A Social Contract That’s Enforceable
|
Mar 12, 2020 |
|
Treating Alzheimer’s Disease as an Autoimmune Condition
|
Mar 05, 2020 |
|
Fishing for New Drugs
|
Feb 27, 2020 |
|
Thoughts on the State of the Antimicrobial Arsenal
|
Feb 20, 2020 |
|
A MedTech Company That Thinks Like a Biopharma
|
Feb 13, 2020 |
|
Tapping the Potential of Psychedelics to Treat Psychiatric Conditions
|
Feb 06, 2020 |
|
Quantifying Neurodegeneration with Precision
|
Jan 30, 2020 |
|
Orasis Developing Eye Drops as Alternative to Reading Glasses
|
Jan 23, 2020 |
|
Reversing Disease Signals
|
Jan 16, 2020 |
|
Turning Cold Tumors Hot
|
Jan 09, 2020 |
|
Stabilizing Neuronal Connections to Treat Cognitive Impairment in Alzheimer’s
|
Jan 02, 2020 |
|
Our Annual Biotech Review/Preview with STAT’s Adam Feuerstein
|
Dec 26, 2019 |
|
An Effort to Eradicate Preventable Blindness
|
Dec 20, 2019 |
|
Seeking Success Where Others Have Failed
|
Dec 19, 2019 |
|
A New Antibiotic with a Unique Mechanism of Action Hits the Market
|
Dec 12, 2019 |
|
Improving Health with Better Data
|
Dec 05, 2019 |
|
An Effort to Bioprint a Transplantable Human Heart
|
Nov 28, 2019 |
|
How Doctors Are Cracking Difficult Cases with a Social Network
|
Nov 21, 2019 |
|
Cala Health Hopes to Win Over Payers and Providers with Its Bioelectric Medicine
|
Nov 14, 2019 |
|
Shaping the Emerging Bioeconomy
|
Nov 07, 2019 |
|
A Belief that Early Interventions Will Be the Key to Treating Alzheimer’s Disease
|
Oct 31, 2019 |
|
Transforming the Study of Microbes with High-Throughput Technology
|
Oct 24, 2019 |
|
Using RNA Diagnostics to Predict Patient Response to Immunotherapies
|
Oct 17, 2019 |
|
How a Clever Business Model May Accelerate the Use of Companion Diagnostics
|
Oct 10, 2019 |
|
Building Cell Therapies with Switches to Modulate Their Activity
|
Oct 03, 2019 |
|
Using Synthetic Biology to Build Intelligence into Cell and Gene Therapies
|
Sep 26, 2019 |
|
A Therapeutic Approach Built on Protein Degradation
|
Sep 19, 2019 |
|
Harnessing AI to Improve Sales and Marketing Decision-Making
|
Sep 12, 2019 |
|
A Doctor’s Quest to Cure His Own Rare Disease
|
Sep 11, 2019 |
|
Athersys Advances Off-the-Shelf Stem Cell Therapy for Stroke
|
Sep 05, 2019 |
|
Enlisting the Innate Immune System to Fight Cancer and other Diseases
|
Aug 29, 2019 |
|
Using AI to Improve Clinical Development
|
Aug 22, 2019 |
|
Addressing the Challenge of Making Antibody-Drug Conjugates
|
Aug 15, 2019 |
|
Targeting Regulators of Genes to Treat Cancer
|
Aug 08, 2019 |
|
Harnessing the Immune System to Diagnose and Treat Cancer
|
Aug 01, 2019 |
|
Using Synthetic Biology to Produce Cannabinoids
|
Jul 25, 2019 |
|
EpicentRx Hopes Rocket-Fuel-Derived Drug Will Propel It
|
Jul 18, 2019 |
|
Using Fruit Flies to Personalize Cancer Therapies
|
Jul 11, 2019 |
|
Bridging the Gap Between Data and Knowledge with AI
|
Jul 04, 2019 |
|
How Virtual Reality May Change the Way Researchers Discover and Develop Drugs
|
Jun 27, 2019 |
|
Addressing the Challenges of Drug Development with a New Market
|
Jun 20, 2019 |
|
Addressing the Challenge of Producing Stem Cell Therapies with Consistency at Scale
|
Jun 13, 2019 |
|
Ensuring a Placebo Response Doesn’t Derail a Clinical Trial
|
Jun 06, 2019 |
|
Using AI to Find New Uses for Validated Drugs
|
May 30, 2019 |
|
Using Digital Health to Change Our Understanding of What Drives Disease
|
May 23, 2019 |
|
Cidara Advances Antiviral Conjugate to Treat and Prevent Flu
|
May 16, 2019 |
|
Building a Drug Empire on Undervalued Assets
|
May 09, 2019 |
|
Bringing Precision Medicine to Autoimmune Disease
|
May 02, 2019 |
|
Fighting Drug-Resistant Fungal Infections
|
Apr 25, 2019 |
|
Accelerating Early-Stage Biotechs
|
Apr 18, 2019 |
|
Agenus Advances Broad Immuno-Oncology Pipeline
|
Apr 11, 2019 |
|
Targeting the Right Proteins to Treat Neurological Diseases
|
Apr 04, 2019 |
|
A Treat Locally, Act Globally Strategy for Treating Cancer
|
Mar 28, 2019 |
|
Squeezing New Possibilities into Cell Therapies
|
Mar 21, 2019 |
|
Industry Calls for New Incentives to Spur Development of New Antibiotics
|
Mar 14, 2019 |
|
Company Seeks to Prove Marine-Derived Alzheimer’s Drug Is No Fish Story
|
Mar 07, 2019 |
|
Targeting the Plasma Proteome to Address Diseases of Aging
|
Feb 28, 2019 |
|
Teaching Scientists to Be Effective Communicators
|
Feb 21, 2019 |
|
Designing Small-Molecule, Immuno-Oncology Drugs That Act Like Biologics
|
Feb 14, 2019 |
|
Biohacking for the Masses
|
Feb 07, 2019 |
|
A Hearts and Minds Strategy for Cardiovascular Disease
|
Jan 31, 2019 |
|
A Drug Hunter Finds Greater Freedom at a Nonprofit Institute
|
Jan 24, 2019 |
|
Attacking IBD Through a Novel Pathway
|
Jan 17, 2019 |
|
Writing the Future of Drug Research with Bioink
|
Jan 10, 2019 |
|
An Effort to Develop Safer and More Effective Immunotherapies
|
Jan 03, 2019 |
|
The Year in Biotech and What to Watch in 2019
|
Dec 27, 2018 |
|
Why One Investor Is Betting on Platform Technologies to Change the World
|
Dec 20, 2018 |
|
Price Transparency and a Healthcare Policy Analyst’s Brush with the Healthcare System
|
Dec 13, 2018 |
|
How a Leading Health Sciences University is Working to Address Homelessness
|
Dec 06, 2018 |
|
Gecko Looks to Broad Applications in Tissue Reconstruction
|
Nov 29, 2018 |
|
The Search for Mediators of Aging
|
Nov 22, 2018 |
|
Using Drug Delivery Technology to Improve ADHD Therapies
|
Nov 15, 2018 |
|
How One Company Is Targeting a Growing Opportunity in Women’s Reproductive Health
|
Nov 08, 2018 |
|
Why an HIV Drug in Development Could Change How Cancer Is Treated
|
Nov 01, 2018 |
|
How the Rise of the Patient-Consumer Is Changing Clinical Trials
|
Oct 25, 2018 |
|
Bringing Real-World Monitoring to Autoimmune Disease
|
Oct 18, 2018 |
|
Using Real-World Evidence to Improve Drug Development
|
Oct 11, 2018 |
|
Enlisting Immunotherapies in the Fight Against Infectious Diseases
|
Oct 04, 2018 |
|
Tackling the Problem of Resistance in Chemotherapy
|
Sep 27, 2018 |
|
Engineering Bacteria for Therapeutic Benefit
|
Sep 20, 2018 |
|
The Promise of Organ-on-a-Chip Technology to Improve Drug Development
|
Sep 13, 2018 |
|
Harnessing AI to Fight Diseases of Aging
|
Sep 06, 2018 |
|
Transforming Clinical Trials with Digital Health Technologies
|
Aug 30, 2018 |
|
Why Foresite Capital is Betting Big on the Convergence of AI and Biotech
|
Aug 23, 2018 |
|
Why Public Health Systems Need to Be Better Prepared for Extreme Weather Events
|
Aug 16, 2018 |
|
Predicting the Unpredictable Off-Target Activities of Drugs
|
Aug 09, 2018 |
|
Why Clinics Providing Stem Cell Therapies not Approved by the FDA Are Creating Growing Concern
|
Aug 02, 2018 |
|
Making Biomedical Discoveries Sooner
|
Jul 26, 2018 |
|
Reinventing Drug Discovery with AI
|
Jul 19, 2018 |
|
Carrying Therapeutic Payloads Across the Blood-Brain Barrier
|
Jul 12, 2018 |
|
Harnessing Bacteria to Improve Skin Health
|
Jul 05, 2018 |
|
How One Accelerator Tries to Give Early-Stage Drug Developers an Edge
|
Jun 28, 2018 |
|
Making Synthetic Biology a Commercial Reality
|
Jun 21, 2018 |
|
Why Behavioral Economics May Turn Irrational Patients Rational
|
Jun 14, 2018 |
|
Pushing the Frontiers of Longevity
|
Jun 07, 2018 |
|
Is Hearing Loss a Necessary Price for Children to Pay for Life-Saving Chemotherapies
|
May 31, 2018 |
|
Why Diagnostics May Be Critical to Reshaping Alzheimer’s Drug Development
|
May 24, 2018 |
|
Why the Diversity of Genomic Data Matters
|
May 17, 2018 |
|
Why Biomarkers May Be the Key to Immuno-Oncology Success
|
May 10, 2018 |
|
Seeing Virtue in Patients
|
May 03, 2018 |
|
When Science Becomes a Cause
|
Apr 26, 2018 |
|
The Pursuit of Healthier, Safer, and More Humane Meat
|
Apr 19, 2018 |
|
A Hidden Killer and Why Patients Face Barriers to Accessing Promising New Drugs for It
|
Apr 12, 2018 |
|
Targeting the Regulators of Genes to Treat Disease
|
Apr 06, 2018 |
|
Price-Fixing Case Against Generic Drugmakers Widens
|
Mar 29, 2018 |
|
Outcomes Erode for Newborns and Mothers in Rural America as Hospitals Lose Obstectric Services
|
Mar 22, 2018 |
|
Why Drug Companies May Soon Become Health Technology Companies
|
Mar 15, 2018 |
|
After Facing Death, Former HR Director Helps Others Get a New Perspective on Life
|
Mar 08, 2018 |
|
Putting Physics to Work in the Fight Against Cancer
|
Mar 01, 2018 |
|
Why Aging Might Best Be Thought of as a Disease
|
Feb 22, 2018 |
|
Looking for a Better Alternative to Chemotherapy for AL Amyloidosis
|
Feb 15, 2018 |
|
A University Spin-Out that Incubates University Spin Outs
|
Feb 08, 2018 |
|
Understanding the Challenges and Opportunities of Patient-Centric Outcomes
|
Feb 02, 2018 |
|
How CellMax Hopes to Change the Diagnosis Cancer with Inexpensive Liquid Biopsy
|
Jan 25, 2018 |
|
How Surveillance and Data Are Bringing Precision to the Treatment of Prostate Cancer
|
Jan 18, 2018 |
|
Why Life Sciences M&A Should Heat up This Year
|
Jan 11, 2018 |
|
The Outlook for Biotech in 2018
|
Jan 04, 2018 |
|
The Year in Biotech and What to Watch in 2018
|
Dec 28, 2017 |
|
The Year in Immuno-Oncology and What to Watch in 2018
|
Dec 21, 2017 |
|
What the Approval of the First Digital Pill Means for the Future of Healthcare
|
Dec 14, 2017 |
|
Why Public Health Systems Need to Be Better Prepared for Extreme Weather Events
|
Dec 07, 2017 |
|
Former CDC Director Takes on World’s Leading Cause of Death
|
Nov 30, 2017 |
|
How a Public-Private Consortium Is Revolutionizing Cancer Drug Discovery
|
Nov 23, 2017 |
|
How Faulty Thinking Can Derail Life Sciences M&A Deals
|
Nov 16, 2017 |
|
Targeting Drug-Resistant Bacteria with an Ancient Enemy
|
Nov 09, 2017 |
|
A Bioelectronic Approach to Treating Autoimmune Diseases
|
Nov 02, 2017 |
|
Harnessing Patient Data to Improve Drug Development Efficiency
|
Oct 26, 2017 |
|
How Colorifix Is Trying to Turn the Textile Industry Green
|
Oct 19, 2017 |
|
Targeting Patients as Sick as Dogs
|
Oct 12, 2017 |
|
A Strategic Investor’s View of the Biotech Investment Landscape
|
Oct 05, 2017 |
|
Bringing Gender Diversity into Biotech Boardrooms
|
Sep 28, 2017 |
|
Why the FDA May Need to Rethink Its Approach to Gene and Cell Therapy
|
Sep 21, 2017 |
|
VBL Targets Brain and other Cancers with Novel Immunotherapy
|
Sep 14, 2017 |
|
What Will It Take to Transform Healthcare to a System Focused on Prediction and Prevention
|
Sep 07, 2017 |
|
Can a Direct Pitch to Patients Drive a Home Run for Obesity Drug
|
Aug 31, 2017 |
|
Why Companies Across Industries Need to Develop a Bio Strategy
|
Aug 24, 2017 |
|
Economist Argues Maximizing Shareholder Value Hurts Drug Innovation
|
Aug 17, 2017 |
|
Partnership Drives Development of Antibiotic to Combat Resistant Gonorrhea
|
Aug 10, 2017 |
|
CIRM-Funded Pipeline of Regenerative Therapies Advances
|
Aug 03, 2017 |
|
Technology Allows Drugmakers to Tag and Authenticate Individual Pills
|
Jul 27, 2017 |
|
Harnessing Mosquitoes to Fight the Spread of Infectious Disease
|
Jul 20, 2017 |
|
Biotech Industry Moves Towards a Patent Cliff
|
Jul 13, 2017 |
|
PvP Takes a Unique Approach to Treating an Autoimmune Disease
|
Jul 06, 2017 |
|
Uncertainty Hangs over the Biotech Sector
|
Jun 29, 2017 |
|
What Others Can Learn from COI’s Approach to Cost-Efficient Drug Development
|
Jun 22, 2017 |
|
Dyadic Seek to Bring Disruptive Technology to Biomanufacturing
|
Jun 15, 2017 |
|
Enlisting the Immune System in the Battle Against Alzheimer’s
|
Jun 08, 2017 |
|
Overcoming the Delivery Challenges of Gene Therapy
|
Jun 01, 2017 |
|
Brexit Sparks Battle to House the EMA
|
May 25, 2017 |
|
New Safety Concerns Identified After FDA Approval of One in Three Drugs
|
May 18, 2017 |
|
Why Climate Change Is a Public Health Concern
|
May 10, 2017 |
|
Reflections on the Progress and Promise of Personalzied Medicines
|
May 04, 2017 |
|
Curing Cancer with Math
|
Apr 27, 2017 |
|
How Healthcare Consumer Find and Use Price Information
|
Apr 20, 2017 |
|
Why Infectious Disease Represents a National Security Threat
|
Apr 13, 2017 |
|
Recent Mumps Outbreaks Raise Question If New Vaccine Is Needed
|
Apr 06, 2017 |
|
Proposed Legislation Would Weaken Genetic Privacy Protections
|
Mar 30, 2017 |
|
How Biomarkers Can Alter the View of and Approach to Alzheimer’s Disease
|
Mar 23, 2017 |
|
The Fight for Personalized Medicine Wages on Many Fronts
|
Mar 16, 2017 |
|
Big Pharma and the Growth and Outlook for Orphan Drugs
|
Mar 09, 2017 |
|
What the Recent Patent Ruling Means for the Future of Gene-Editing Technology
|
Mar 02, 2017 |
|
Weighing What Limits Should Be Put on Gene Editing
|
Feb 23, 2017 |
|
Enlisting the Immune System in the War on Cancer
|
Feb 16, 2017 |
|
Why Scientists Must Also Be Advocates
|
Feb 09, 2017 |
|
Sernova Eyes Range of Disease for Implantable Cell Technology
|
Feb 02, 2017 |
|
Stratus Wants to Demonstrate Its Telehealth Fluency
|
Jan 26, 2017 |
|
Regeneron Embraces Genetics as Fundamental to Drug Development
|
Jan 19, 2017 |
|
Despite FDA Setback, KemPharm Advancing Prodrug Pipeline
|
Jan 12, 2017 |
|
Using digital technologies to improve diagnosis and treatment of mental health patients
|
Jan 05, 2017 |
|
Biotech in 2016 and the Year Ahead with TheStreet’s Adam Feuerstein
|
Dec 29, 2016 |
|
Harnessing Gut Bacteria to Treat Disease
|
Dec 22, 2016 |
|
A Look at What’s Ahead for Biopharma in 2017
|
Dec 15, 2016 |
|
AMA Wants Docs to Have Seat at mHealth Table
|
Dec 08, 2016 |
|
Testing of New HIV Vaccine Carries Hopes of a Breakthrough
|
Dec 01, 2016 |
|
Centrexion Takes Aim at Pain with Growing Portfolio of Non-Opioid Therapeutics
|
Nov 24, 2016 |
|
Bringing Women into Biotech Boardrooms
|
Nov 18, 2016 |
|
Novartis Deal Validates Perlara’s Approach to Rare Disease Drug Discovery
|
Nov 10, 2016 |
|
Harvesting the Aquatic Microbiome for New Drugs
|
Nov 03, 2016 |
|
How TwoXAR Is Using Big Data to Accelerate Drug Discovery
|
Oct 27, 2016 |
|
Developer of innovative catheter for cancer drugs turns to crowdfunding
|
Oct 20, 2016 |
|
Harnessing Real World Samples and Data to Speed Biomedical Research
|
Oct 13, 2016 |
|
A Rich Pipeline Expected to Drive Industry’s Growth
|
Oct 06, 2016 |
|
Harnessing Biology to Transform the Economy
|
Sep 29, 2016 |
|
How a Predictive Diagnostic Can Reduce Preterm Births
|
Sep 21, 2016 |
|
Building Better Drugs for Psychiatric Disorders by Targeting the Causes
|
Sep 15, 2016 |
|
The Role of PBMs in the Controversy over Drug Pricing
|
Sep 08, 2016 |
|
Why a Rare Genetic Disease May Shed Light on Normal Aging
|
Sep 01, 2016 |
|
Battling Zika and Other Diseases Like It
|
Aug 25, 2016 |
|
Chronicling a Trailblazer of the Genomics Age
|
Aug 18, 2016 |
|
Great Progress, but Concerns Persist About Cancer Care in America
|
Aug 11, 2016 |
|
Improving Healthcare by Addressing the Most Challenging Patients
|
Aug 04, 2016 |
|
The Case for Chasing Unpopular Indications
|
Jul 28, 2016 |
|
Improving Drug Development through Better Use of Biomarkers
|
Jul 21, 2016 |
|
Measuring the Value of Incubators and Accelerators
|
Jul 14, 2016 |
|
Enlisting New and Old Tools to Combat Antibiotic Resistance
|
Jul 07, 2016 |
|
Advancing Cancer Care with New Diagnostic Tools
|
Jun 30, 2016 |
|
A Biotech Reinvents Itself and How to Price Drugs
|
Jun 23, 2016 |
|
Using Technology to Modernize Preclinical Development
|
Jun 16, 2016 |
|
Can the Biotech Industry Stay on Track through Innovative Pricing
|
Jun 08, 2016 |
|
Wall Street Turns Its Eyes to ASCO
|
Jun 02, 2016 |
|
Understanding the Disease It Never Was on House
|
May 26, 2016 |
|
Why the State of Innovation Is Encouraging
|
May 19, 2016 |
|
Can Market Forces Fix Drug Pricing
|
May 12, 2016 |
|
Digital Health Device Seeks to Push Beyond Cannabis to Test Food, Air, and Water
|
May 05, 2016 |
|
Why the Cancer Moonshot Offers a Chance to Rethink Funding Priorities
|
Apr 28, 2016 |
|
Medtronic Advances Toward an Artificial Pancreas
|
Apr 21, 2016 |
|
Using Real-Time Data to Detect HIV Outbreaks
|
Apr 14, 2016 |
|
Why Pharma Needs to Forge New Drug Pricing Models
|
Apr 07, 2016 |
|
Gensight Targets Gene Therapy on Diseases that Blind
|
Mar 31, 2016 |
|
A Vial Problem: How We Waste $3 Billion of Cancer Drugs a Year
|
Mar 24, 2016 |
|
The Havoc-Wreaking Zombies Lurking in Life Sciences Boardrooms
|
Mar 17, 2016 |
|
New FDA Chief Faces Challenges
|
Mar 10, 2016 |
|
Seeking a Best-in-Class Antibody at Bargain Basement Prices
|
Mar 03, 2016 |
|
Pharma Bro, Price Controls, and the Quest to Balance Innovation with Affordability
|
Feb 25, 2016 |
|
California’s Stem Cell Agency Plots Its Future
|
Feb 18, 2016 |
|
ViaCyte Pursues ”Functional Cure” for Type 1 Diabetes
|
Feb 11, 2016 |
|
Building a Better Pain Pill
|
Feb 04, 2016 |
|
Project GENIE Hopes to Make Precision Medicine a Reality
|
Jan 28, 2016 |
|
FDA Wants Industry to Guard Against Cybersecurity Risks of Medical Devices
|
Jan 21, 2016 |
|
Pharma’s Leadership Vacuum and Its Price to the Industry
|
Jan 14, 2016 |
|
Permanent R&D Tax Credit a Boost to Life Sciences
|
Jan 07, 2016 |
|
Biotech in 2015 and the Year Ahead with TheStreet’s Adam Feuerstein
|
Dec 31, 2015 |
|
Trends Shaping the New Health Economy in 2016
|
Dec 24, 2015 |
|
Declining R&D Productivity Continues to Plague Big Pharma
|
Dec 17, 2015 |
|
Searching for Solutions to Rising Specialty Drug Prices
|
Dec 10, 2015 |
|
Biohackers Seek a Faster, Cheaper Path to Insulin
|
Dec 03, 2015 |
|
A Scorecard to Improve Drugmakers’ Transparency
|
Nov 25, 2015 |
|
Forget the Chemistry Set, Mom, I Want a Bioreactor
|
Nov 19, 2015 |
|
Ensuring Biological Tools Benefit the Environment
|
Nov 13, 2015 |
|
New SEC Rules Open Crowdfunding to the Masses
|
Nov 05, 2015 |
|
Harnessing Biology to Address Global Challenges
|
Oct 29, 2015 |
|
Immunotherapies ETF Lets Biotech Investors Bet on Emerging Sector
|
Oct 22, 2015 |
|
Biotech Investors Turn Their Eyes to Policy Matters
|
Oct 16, 2015 |
|
Why the MedTech Industry Should Worry About Future Innovation
|
Oct 08, 2015 |
|
Rare Disease Drug Developer Shows Speed of Business Model
|
Oct 01, 2015 |
|
Ensuring Value-Based Care Addresses What Matters to Patients
|
Sep 24, 2015 |
|
California, Aid-in-Dying, and What We’ve Learned from Oregon
|
Sep 17, 2015 |
|
FDA Guidance on Names for Biologics and Biosimilars and its Implications
|
Sep 10, 2015 |
|
Understanding the Cost and Value of Cancer Therapies
|
Sep 03, 2015 |
|
Jimmy Carter’s Final Wish: Eradicating Guinea Worm
|
Aug 27, 2015 |
|
The Quest for a Pink Viagra
|
Aug 20, 2015 |
|
Free Speech Ruling May Force FDA to Rethink Off-Label Marketing
|
Aug 14, 2015 |
|
Drugmakers Often Late to Report Serious Side Effects
|
Aug 06, 2015 |
|
When Hospital Cause, Rather than Cure, Deadly Infections
|
Jul 30, 2015 |
|
Rethinking the Value and Price of Drugs
|
Jul 23, 2015 |
|
Harnessing Stem Cells to Test Drug Safety
|
Jul 16, 2015 |
|
CrowdMed Enlists the Wisdom of Crowds to Solve Medical Mysteries
|
Jul 09, 2015 |
|
Biotech’s Record Performance and Looming Threats
|
Jul 02, 2015 |
|
What a Decade of Investment Tells Us about the Health of Biotech
|
Jun 25, 2015 |
|
What Activist Investors Can Teach Biotech Companies
|
Jun 18, 2015 |
|
ALS Fight Carries Muller from Patient to Biotech CEO
|
Jun 11, 2015 |
|
Examining the State of Sleep
|
Jun 05, 2015 |
|
TheStreet’s Adam Feuerstein Previews ASCO 2015
|
May 28, 2015 |
|
Home-Brew Morphine, Dual Use Technology, and the Biologist’s Repsonsibilities
|
May 20, 2015 |
|
Reinventing Tech Transfer
|
May 14, 2015 |
|
Thinking Narrowly About Antibiotics
|
May 07, 2015 |
|
Promise Shown in Different Approach to Alzheimer’s
|
Apr 30, 2015 |
|
Innovative Drugs Drive Big Increase in U.S. Spending
|
Apr 23, 2015 |
|
Ensuring Digital Health Technologies Benefit Older People
|
Apr 16, 2015 |
|
How the Sugar Industry Influenced Research to Protect Its Interests
|
Apr 10, 2015 |
|
Examining The White House’s Plan to Combat Drug-Resistant Bacteria
|
Apr 03, 2015 |
|
Weighing Adverse Events to Get at a Drug’s Real Costs
|
Mar 26, 2015 |
|
How One Company Is Reinventing Drug Development
|
Mar 19, 2015 |
|
Why Patent Trolling Threatens Biopharma
|
Mar 13, 2015 |
|
Shifting Venture Investment Raises Concerns
|
Mar 05, 2015 |
|
Will Policy Triumph Over Politics in 21st Century Cures Act
|
Feb 26, 2015 |
|
Democratizing the World of Healthcare Analytics
|
Feb 19, 2015 |
|
Will Funding for Obama’s Precision Medicine Initiative Match Its Ambition
|
Feb 12, 2015 |
|
Should Investors Temper Their Enthusiasm for CAR-T Therapies
|
Feb 05, 2015 |
|
What to Do About the United States’ Declining Investment in R&D
|
Jan 29, 2015 |
|
Why Big Pharma Hasn’t Been Able to Fix Its Revenue Gap with M&A
|
Jan 22, 2015 |
|
Remembering Industry Pioneer Ron Cape
|
Jan 15, 2015 |
|
Moving from Chronic Therapies to Cures
|
Jan 08, 2015 |
|
What’s in Store for the Biotech Industry in 2015
|
Dec 31, 2014 |
|
A Look at the Year That Was in Biotech
|
Dec 24, 2014 |
|
Why Privacy Concerns May Limit Big Data’s Payoff
|
Dec 18, 2014 |
|
Calculating the Cost of Drug Development and What it Means
|
Dec 11, 2014 |
|
How New Funding Models Are Accelerating Drug Development
|
Dec 04, 2014 |
|
Telemedicine Grows, but Reimbursement Remains an Obstacle
|
Nov 28, 2014 |
|
The Power of IBM’s Watson Is Coming to an App Near You
|
Nov 20, 2014 |
|
Brittany Maynard and the Debate over the Right to Die
|
Nov 13, 2014 |
|
What’s Driving the Booming Market for Orphan Drugs
|
Nov 06, 2014 |
|
Why Interoperability Is Much More than a Technology Problem
|
Oct 30, 2014 |
|
The Lean Startup Takes Hold in the Life Sciences
|
Oct 23, 2014 |
|
Enlisting Monoclonal Antibodies to Combat Bacterial Resistance
|
Oct 16, 2014 |
|
The Forces Bringing Disruptive Change to Healthcare
|
Oct 09, 2014 |
|
How One Foundation is Getting the Biggest Bang for Its R&D Bucks
|
Oct 02, 2014 |
|
International Collaboration Seeks to Drive Breakthroughs in Progressive MS
|
Sep 24, 2014 |
|
Will Increased FDA Regulation of Diagnostics Speed or Slow Development of Personalized Medicine
|
Sep 18, 2014 |
|
Using Human Biology to Improve R&D
|
Sep 11, 2014 |
|
Reengineering Drug Discovery and Development
|
Sep 04, 2014 |
|
The Year in Biotech So Far and What’s Ahead
|
Aug 28, 2014 |
|
Epirus Sees Opportunities for Biosimilars Outside U.S.
|
Aug 21, 2014 |